Realeve Wins Gold in 2023 Merit Awards for Healthcare

Realeve is issued US and EU patents

Realeve has been issued three additional patents in the US and Europe. US 11,679,263 SYSTEMS AND METHODS FOR IMPROVING HEADACHE PAIN Issued on June 20, 2023 EP 3386583 SURGICAL TOOLS…

Unity HA Awarded Breakthrough Device Designation from FDA

Unity HA Awarded Breakthrough Device Designation from FDA for Implantable Neurostimulation Technology to Treat Cluster Headache Pain

Results of double-blind, randomized controlled trial published in The Lancet

Unity HA announces the publication of the results of a randomized, sham-controlled, parallel group, double-blind, safety and efficacy study at 21 headache centers in the USA. This publication in…

Unity HA Acquires Autonomic Technologies Intellectual Property

Autonomic Technologies, Inc’s (ATI) intellectual property has been acquired by a new owner, Unity HA. Led by Dr. Peter Bonutti, this new company’s goal is to continue to advance cost…